| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 775 | $181K | $232.95 | May 8, 2025 | Direct |
| ALNYLAM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 1.56K | May 8, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 8, 2025 | 2 | $0 | 4 | May 12, 2025 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Mar 7, 2023 | 1 | $0 | 4 | Mar 9, 2023 | Director |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Mar 7, 2023 | 0 | $0 | 3 | Mar 9, 2023 | Director |